Cardiovascular-Kidney-Metabolic Overlap in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
John W. Ostrominski(Brigham and Women's Hospital), Muthiah Vaduganathan(Harvard University), Brian Claggett(National Heart Lung and Blood Institute), Pardeep S. Jhund(Copenhagen University Hospital), Finnian R. Mc Causland(Brigham and Women's Hospital), James Lay‐Flurrie(Bayer (United Kingdom)), John J.V. McMurray(Western Infirmary), Marc A. Pfeffer(Brigham and Women's Hospital), Faı̈ez Zannad(Inserm), Bertram Pitt(Bayer (Germany)), Michael R. Zile(Wm. Jennings Bryan Dorn VA Medical Center), Scott D. Solomon(Brigham and Women's Hospital), Carolyn S.P. Lam, Zi Michael Miao(Brigham and Women's Hospital), Akshay S. Desai(Brigham and Women's Hospital), Antonieta Bomfim Wirtz(Bayer (Germany)), Prabhakar Viswanathan(Bayer (United States)), Inder S. Anand(University of Minnesota)
Cited by 39
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k